Categories: News

Milestone Scientific to Present at Dawson James Securities 6th Annual Small Cap Growth Conference on October 21, 2021

ROSELAND, N.J., Oct. 18, 2021 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that Arjan Haverhals, Chief Executive Officer and President of Milestone Scientific, will present at the Dawson James Securities Small Cap Growth Conference being held on October 21, 2021 at the Wyndham Grand Hotel in Jupiter, Florida.

Mr. Haverhals will present on Thursday, October 21st at 1:10 pm Eastern Time and will also be participating in one-on-one meetings with qualified investors throughout the conference.

The live webcast and subsequent archived recordings for the presentation can be accessed here and on the investor relations section of the Milestone Scientific website at https://www.milestonescientific.com/investors.

About Dawson James Securities
Dawson James Securities, Inc., a member of FINRA/SIPC, is a full-service investment bank headquartered in Boca Raton, FL. http://www.dawsonjames.com.

About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS), a technology focused medical research and development company that patents, designs and develops innovative injection technologies and instruments for medical, dental and cosmetic applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.

Contact: David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020

Staff

Recent Posts

Scott Leune Names 2026 Sponsors Selected to Support Dental Practice Growth and Operations

SAN ANTONIO, Dec. 29, 2025 /PRNewswire/ -- Scott Leune Education today announced its 2026 sponsors,…

47 minutes ago

New Horizon Medical Solutions Announces the Acquisition of the Applied Tissue Technologies Business Assets

New Horizon Medical Solutions acquires transparent negative pressure wound therapy device and micro grafting kit…

47 minutes ago

Medical Care Technologies (OTC PINK:MDCE) Achieves Global Distribution Approval from Apple’s iOS App Store

MESA, AZ / ACCESS Newswire / December 29, 2025 / Medical Care Technologies Inc. (OTC…

47 minutes ago

Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

4 hours ago

Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

4 hours ago